Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are known to cause late-onset, familial forms of Parkinson’s Disease, with prevalence up to 40% in specific populations. These mutations are also linked to sporadic PD, highlighting the importance of the related protein in the development of the disease. LRRK2 is a large, complex, multi-domain protein, with two main enzymatic activities: a GTPase domain (bearing three pathogenic mutations) and a kinase domain, in which the most common mutation (G2019S) is found. Even though the precise cellular functions of LRRK2 are not known, LRRK2 has been proposed to take part in key signaling pathways, ultimately governing cellular functions such as synaptic transmission, synaptic vesicle dyn...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying ...
AbstractThe leucine-rich repeat kinase 2 mutation G2019S in the kinase-domain is the most common gen...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying ...
The leucine-rich repeat kinase 2 mutation (LRRK2) G2019S in the kinase-domain is the most common gen...
The leucine-rich repeat kinase 2 mutation (LRRK2) G2019S in the kinase-domain is the most common gen...
Parkinson\u27s disease (PD) is a debilitating and progressive neurodegenerative disorder that affect...
SummaryMutations in α-synuclein and Leucine-rich repeat kinase 2 (LRRK2) are linked to autosomal dom...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of Park...
Parkinson disease is the second most common neurodegenerative disorder affecting 4 million people wo...
The leucine-rich repeat kinase 2 (LRRK2) gene was found to play a role in the pathogenesis of both f...
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause Parkinson’s disease with a similar clinical ...
Mutations in LRRK2 play a critical role in both familial and sporadic Parkinson’s disease (PD). Up t...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of famili...
Citation: Xiong, Y. L., Neifert, S., Karuppagounder, S. S., Stankowski, J. N., Lee, B. D., Grima, J....
Parkinson\u27s disease (PD) is a debilitating and progressive neurodegenerative disorder that affect...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying ...
AbstractThe leucine-rich repeat kinase 2 mutation G2019S in the kinase-domain is the most common gen...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying ...
The leucine-rich repeat kinase 2 mutation (LRRK2) G2019S in the kinase-domain is the most common gen...
The leucine-rich repeat kinase 2 mutation (LRRK2) G2019S in the kinase-domain is the most common gen...
Parkinson\u27s disease (PD) is a debilitating and progressive neurodegenerative disorder that affect...
SummaryMutations in α-synuclein and Leucine-rich repeat kinase 2 (LRRK2) are linked to autosomal dom...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of Park...
Parkinson disease is the second most common neurodegenerative disorder affecting 4 million people wo...
The leucine-rich repeat kinase 2 (LRRK2) gene was found to play a role in the pathogenesis of both f...
Mutations in leucine-rich repeat kinase 2 (LRRK2) cause Parkinson’s disease with a similar clinical ...
Mutations in LRRK2 play a critical role in both familial and sporadic Parkinson’s disease (PD). Up t...
Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene represent the most common cause of famili...
Citation: Xiong, Y. L., Neifert, S., Karuppagounder, S. S., Stankowski, J. N., Lee, B. D., Grima, J....
Parkinson\u27s disease (PD) is a debilitating and progressive neurodegenerative disorder that affect...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying ...
AbstractThe leucine-rich repeat kinase 2 mutation G2019S in the kinase-domain is the most common gen...
Parkinson’s disease (PD) is a progressive neurodegenerative disorder for which no disease-modifying ...